• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Adient plc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    6/10/25 4:15:15 PM ET
    $ADNT
    Auto Parts:O.E.M.
    Consumer Discretionary
    Get the next $ADNT alert in real time by email
    adnt-20250610
    0001670541FALSE00016705412025-06-102025-06-10

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of
    the Securities Exchange Act of 1934

    Date of Report (date of earliest event reported): June 10, 2025

    ADIENT PLC
    (Exact name of registrant as specified in its charter)

    Ireland001-3775798-1328821
    (State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification Number)
     3 Dublin Landings, North Wall Quay
    Dublin 1, Ireland D01 H104
    (Address of principal executive offices)

    Registrant’s telephone number, including area code: 734-254-5000

    Not applicable
    (Former name or former address, if changed since last report)

    Securities registered pursuant to Section 12(b) of the Act:
    Title of classTrading symbol(s)Name of exchange on which registered
    Ordinary Shares, par value $0.001ADNTNew York Stock Exchange


    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrants under any of the following provisions (see General Instruction A.2. below):

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17     CFR 240.14d-2(b))

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




    Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐







    Item 7.01. Regulation FD Disclosure.

    Representatives of Adient plc expect to hold meetings with certain investors in June 2025. A copy of the presentation materials that will be used during these meetings is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

    The information contained in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.


    Item 9.01. Financial Statements and Exhibits.

    (d) Exhibits.
    EXHIBIT INDEX
    Exhibit No.Exhibit Description
    99.1
    Adient plc Investor Presentation June 2025.
    104Cover Page Interactive Data File (the Cover Page Interactive Data File is embedded within the Inline XBRL document).



    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    ADIENT PLC
    Date: June 10, 2025By:/s/ Heather M. Tiltmann
    Name:Heather M. Tiltmann
    Title:
    Executive Vice President, Chief Legal and Human Resources Officer, and Corporate Secretary


    Get the next $ADNT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ADNT

    DatePrice TargetRatingAnalyst
    4/23/2025$14.00Neutral
    Citigroup
    3/4/2025$24.00 → $18.00Neutral → Underperform
    BofA Securities
    12/16/2024$27.00 → $20.00Overweight → Equal Weight
    Wells Fargo
    11/21/2024$30.00 → $24.00Buy → Neutral
    BofA Securities
    9/10/2024$24.00Hold
    Deutsche Bank
    9/5/2024Peer Perform
    Wolfe Research
    7/1/2024$26.00Underperform → Neutral
    Exane BNP Paribas
    4/10/2024$41.00 → $37.00Overweight → Equal Weight
    Barclays
    More analyst ratings